BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2706633)

  • 1. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.
    Jansen G; Westerhof GR; Kathmann I; Rademaker BC; Rijksen G; Schornagel JH
    Cancer Res; 1989 May; 49(9):2455-9. PubMed ID: 2706633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large diversity in transport-mediated methotrexate resistance in human leukemia cell line CCRF-CEM established in a high concentration of leucovorin.
    Asai S; Miyachi H; Kobayashi H; Takemura Y; Ando Y
    Cancer Sci; 2003 Feb; 94(2):210-4. PubMed ID: 12708499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity.
    Abedi M; Rahgozar S; Esmaeili A
    Cancer Med; 2020 May; 9(10):3537-3550. PubMed ID: 32176452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics.
    Kager L; Cheok M; Yang W; Zaza G; Cheng Q; Panetta JC; Pui CH; Downing JR; Relling MV; Evans WE
    J Clin Invest; 2005 Jan; 115(1):110-7. PubMed ID: 15630450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate modulates folate phenotype and inflammatory profile in EA.hy 926 cells.
    Summers CM; Hammons AL; Arora J; Zhang S; Jochems J; Blair IA; Whitehead AS
    Eur J Pharmacol; 2014 Jun; 732():60-7. PubMed ID: 24657277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication of methotrexate-loaded gold nanoconjugates and its enhanced anticancer activity in breast cancer.
    Chaudhari R; Patel P; Meghani N; Nasra S; Kumar A
    3 Biotech; 2021 Apr; 11(4):175. PubMed ID: 33927966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of methotrexate linked to an anti-EL4-lymphoma antibody by EL4 cells.
    Uadia P; Blair AH; Ghose T
    Cancer Immunol Immunother; 1983; 16(2):127-9. PubMed ID: 6559102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody directed targeting of methotrexate-containing small unilamellar vesicles.
    Singh M; Faulkner G; Ghose TI; Mezei M
    Cancer Immunol Immunother; 1988; 27(1):17-25. PubMed ID: 3293779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of ABCG1 is associated with methotrexate resistance in acute lymphoblastic leukemia cells.
    Chen Y; Fang H; Sun H; Wu X; Xu Y; Zhou BS; Li H
    Front Pharmacol; 2023; 14():1331687. PubMed ID: 38259297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth suppression of four cancer cells by hyperbaric nitrous oxide and methotrexate.
    Jung CH; Sim JY; Ahn W
    Korean J Anesthesiol; 2010 Jan; 58(1):61-9. PubMed ID: 20498814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic modeling of chemotherapeutic effects: application of a transit compartment model to characterize methotrexate effects in vitro.
    Lobo ED; Balthasar JP
    AAPS PharmSci; 2002; 4(4):E42. PubMed ID: 12646013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipophilic Prodrug of Methotrexate in the Membrane of Liposomes Promotes Their Uptake by Human Blood Phagocytes.
    Tretiakova DS; Khaidukov SV; Babayants AA; Frolova IS; Shcheglovitova ON; Onishchenko NR; Vodovozova EL
    Acta Naturae; 2020; 12(1):99-109. PubMed ID: 32477604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer conjugates and cocktails based on methotrexate and nucleoside synergism.
    Vortherms AR; Dang HN; Doyle RP
    Clin Med Oncol; 2009 Mar; 3():19-26. PubMed ID: 20689607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of Clinical Applications and Side Effects of Methotrexate in Ophthalmology.
    Wang G; Peng X
    J Ophthalmol; 2020; 2020():1537689. PubMed ID: 32850138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RX-3117 (Fluorocyclopentenyl-Cytosine)-Mediated Down-Regulation of DNA Methyltransferase 1 Leads to Protein Expression of Tumor-Suppressor Genes and Increased Functionality of the Proton-Coupled Folate Carrier.
    Sarkisjan D; Julsing JR; El Hassouni B; Honeywell RJ; Kathmann I; Matherly LH; Lee YB; Kim DJ; Peters GJ
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32295203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocytosis of GPI-linked membrane folate receptor-alpha.
    Rijnboutt S; Jansen G; Posthuma G; Hynes JB; Schornagel JH; Strous GJ
    J Cell Biol; 1996 Jan; 132(1-2):35-47. PubMed ID: 8567728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein.
    Garin-Chesa P; Campbell I; Saigo PE; Lewis JL; Old LJ; Rettig WJ
    Am J Pathol; 1993 Feb; 142(2):557-67. PubMed ID: 8434649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer chemosensitivity changes between the original and recurrent tumors after successful chemotherapy selected according to the sensitivity assay.
    Nio Y; Tamura K; Tsubono M; Kawabata K; Masai Y; Hayashi H; Ishigami S; Araya S; Imamura M
    Ann Surg; 1995 Jan; 221(1):89-99. PubMed ID: 7826166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the cytoplasmic accumulation of 5-methyltetrahydrofolate in MA104 cells is independent of folate receptor regulation.
    Kamen BA; Johnson CA; Wang MT; Anderson RG
    J Clin Invest; 1989 Nov; 84(5):1379-86. PubMed ID: 2478584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth-inhibitory effects of 5,10-dideazatetrahydrofolic acid on variant murine L1210 and human CCRF-CEM leukemia cells with different membrane-transport characteristics for (anti)folate compounds.
    Jansen G; Westerhof GR; Kathmann I; Rijksen G; Schornagel JH
    Cancer Chemother Pharmacol; 1991; 28(2):115-7. PubMed ID: 2060081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.